Skip to main content
TipRanks
Go Ultimate75% OFF

James Edward Machek Insider Profile

4 Followers

James Edward Machek, former VP-Research & Development at Endologix, holds 33.22K shares in Endologix (Ticker: ELGXQ).

James Edward Machek's Trading History

ELGXQ
Endologix
Jun 02, 2016―Uninformative Buy―$631.26
ELGXQ
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 02, 2016Informative Sell$12.01K957$12.55+62.00%
Jun 02, 2016Uninformative Buy$0.007,535$0.00―
May 27, 2016Informative Sell$82.94K6,500$12.76+63.50%
May 25, 2016Uninformative Buy$0.002,023$0.00―
May 25, 2016Uninformative Sell$0.00761$0.00―

You May Also Like

James Edward Machek insider profile FAQ

What is the percentage of profitable transactions made by James Edward Machek?
The percentage of profitable transactions made by James Edward Machek is 100%.
What is the average return per transaction made by James Edward Machek?
The average return per transaction made by James Edward Machek is 45.20%.
What stocks does James Edward Machek hold?
James Edward Machek holds: ELGXQ stocks.
What was James Edward Machek's most profitable transaction?
James Edward Machek’s most profitable transaction was an Informative Sell of ELGXQ stock on May 27, 2016. The return on the trade was 63.50%.
What is James Edward Machek's role in Endologix?
James Edward Machek's role in Endologix is VP-Research & Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.